Xvivo Perfusion AB (publ) ( XVIPF) - Stock Earnings
XVIPF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 22, 2026, midnight | — / — | — | — / — | — |
XVIPF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 3.4 million USD | 24.5 million USD |
| 2026Q1 | 3.8 million USD | 25.2 million USD |
| 2026Q2 | 1.7 million USD | 24.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
XVIPF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 9.1 million USD | 59.3 million USD |
| 2024 | 15.7 million USD | 74.8 million USD |
| 2025 | 2.7 million USD | 88.0 million USD |
| 2026 Est. | — | — |
XVIPF
Price: $21.80
52 week price:
Earnings Per Share: 0.29 USD
P/E Ratio: 89.90
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 686.7 million